NL-OMON35749尚未招募4 期
A longitudinal randomized clinical trial of participants satisfaction of two mandibular implant-retained overdentures, with ball, bar or locator attachment, in patients with severe resorption of the mandible. - Dental implants and suprastructure trial 2 (the suprastructure trial)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 660
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Edentulous upper and lower jaw.
- •2. The need of 2 dental implants in the lower jaw urged by dental surgeon and dentist during a combined consultation.
排除标准
- •1. Simultaneous extractions or vestibuloplasty.
- •2. Bone-augmentation.
- •3. Simultaneous placement of dental implants in the maxilla.
- •4. Immune compromised patients.
- •5. Patients that underwent radiotherapy in the head and neck area.
- •6. Infections in the vicinity of the planned implant sites.
- •7. Pregnancy or lactating.
- •8. Less than 3 months after the last tooth-extraction.
- •9. Treated or under treatment with oral or intravenous amino-bisphosphonates.
- •10. Earlier placed dental implants.
研究者
相似试验
尚未招募
4 期
A longitudinal randomized clinical trial of participants satisfaction of three or four mandibular implant-retained overdentures, with bar attachment, in patients with severe resorption of the mandible.dental implantsmandibular implant-retained overdentureprosthesis1002445010005944NL-OMON36109Academisch Medisch Centrum420
已完成
不适用
A clinical trial to demonstrate the effectiveness in function of an indigenously developed dental implant system (NMITLI)CTRI/2011/11/002149Maulana Azad Institute of Dental Sciences New Delhi60
已完成
3 期
R-Anti-D immunoglobulin to prevent Rh-D sensitisation of Rh-negative pregnant womeCTRI/2017/03/008101Bharat Serums and Vaccines Ltd215
招募中
不适用
A comparative prospective randomized clinical study of Premixed Endocem and ProRoot MTA as root-end filling materials in endodontic surgery.KCT0007084Yonsei University Health System, Dental Hospital80
已完成
3 期
REGiM: Prolonged treatment with darbepoetin alpha (EPO), with/without recombinant human granulocyte colony stimulating factor (G-CSF), versus best supportive care in patients with low-risk myelodysplastic syndromes (MDS)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (acute myeloid)Myelodysplastic syndromesCancerISRCTN65652441Barts and The London NHS Trust (UK)1,200